Cargando…
Androgen receptor expression in male breast carcinoma: lack of clinicopathological association
Androgen receptor (AR) expression was retrospectively analysed in 47 primary male breast carcinomas (MBCs) using a monoclonal antibody on formalin-fixed, paraffin-embedded tissues. AR immunopositivity was detected in 16 out of 47 (34%) cases. No association was found with patient age, tumour stage,...
Autores principales: | Pich, A, Margaria, E, Chiusa, L, Candelaresi, G, Canton, O Dal |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362653/ https://www.ncbi.nlm.nih.gov/pubmed/10070897 http://dx.doi.org/10.1038/sj.bjc.6690153 |
Ejemplares similares
-
Expression of androgen receptor and prostate-specific antigen in male breast carcinoma
por: Kidwai, Noman, et al.
Publicado: (2004) -
Androgen receptor expression and its relationship with clinicopathological parameters in an Iranian population with invasive breast carcinoma
por: Mohammadizadeh, Fereshteh, et al.
Publicado: (2014) -
Expression of androgen receptor in invasive ductal breast carcinomas: a clinicopathological study from Jordan
por: Obeidat, Fatima Nouri, et al.
Publicado: (2018) -
Androgen receptor expression in endometrial carcinoma and its correlation with clinicopathologic features
por: Hashmi, Atif Ali, et al.
Publicado: (2018) -
Clinicopathological features and androgen receptor expression in triple negative breast cancer at Lagos, Nigeria
por: Haruna, Muibat, et al.
Publicado: (2022)